Related Experiment Video

Updated: May 16, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Disease-modifying therapy of pediatric multiple sclerosis

Tanuja Chitnis1

  • 1Harvard Medical School, Boston, MA 02115, USA. tchitnis@partners.org

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|December 11, 2012
PubMed

Insights

Pediatric multiple sclerosis (MS) is more common and presents with relapsing forms and cognitive issues. Future studies will improve treatment for children with MS.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Multiple sclerosis (MS) is increasingly diagnosed in pediatric populations.
  • Improved awareness and specialized care enhance pediatric MS management.
  • Pediatric MS predominantly manifests as a relapsing form.

Purpose of the Study:

  • To review the current understanding of pediatric multiple sclerosis.
  • To highlight the unique clinical presentation and treatment challenges in children.
  • To discuss the implications of new legislation on pediatric MS research.

Main Methods:

  • Literature review of pediatric multiple sclerosis cases and treatments.
  • Analysis of clinical presentation differences between pediatric and adult MS.
  • Examination of current therapeutic strategies and off-label drug use.

Main Results:

  • Pediatric MS patients exhibit frequent relapses and prominent cognitive deficits.
  • Beta interferons and glatiramer acetate are common off-label treatments.
  • Lack of pediatric-specific randomized clinical trials currently exists.

Conclusions:

  • Cognitive impairment is a key feature of pediatric MS, differing from adult presentations.
  • Current treatments are often used off-label, necessitating further research.
  • Upcoming pediatric studies mandated by legislation will provide crucial efficacy and dosing data.

More Related Videos

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...